UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

Annals of oncology, 2012-06, Vol.23 (6), p.1422-1427

2012

Volltextzugriff (PDF)

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Cancer chemotherapy and pharmacology, 2013-01, Vol.71 (1), p.245-255

2013

Volltextzugriff (PDF)

Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial

Intensive care medicine, 2021-01, Vol.47 (1), p.49-59

2021

Volltextzugriff (PDF)

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

Breast cancer research and treatment, 2008-12, Vol.112 (3), p.419-427

2008

Volltextzugriff (PDF)

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

British journal of cancer, 2008-12, Vol.99 (11), p.1775-1785

2008

Volltextzugriff (PDF)

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Cancer chemotherapy and pharmacology, 2012-02, Vol.69 (2), p.533-546

2012

Volltextzugriff (PDF)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

British journal of cancer, 2010-09, Vol.103 (7), p.1048-1056

2010

Volltextzugriff (PDF)

Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)

Annals of oncology, 2018-10, Vol.29, p.viii53-viii53

2018

Volltextzugriff (PDF)

Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

Annals of oncology, 2018-10, Vol.29, p.viii73-viii73

2018

Volltextzugriff (PDF)

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer

Translational oncology, 2018-04, Vol.11 (2), p.467-476

2018

Volltextzugriff (PDF)

Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer

Pneumologie (Stuttgart, Germany), 2017-03, Vol.71 (3), p.151

2017

Volltextzugriff (PDF)

Radiation exposure before and after the introductionof a dedicated total-body CT protocolin multitrauma patients

Emergency radiology, 2013-12, Vol.20 (6), p.507-512

2013

Volltextzugriff (PDF)

Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism

Pneumologie (Stuttgart, Germany), 2015-06, Vol.69 (6), p.350

2015

Volltextzugriff (PDF)

Effect of the haemoglobin level on neurologic outcome in patients with severe traumatic brain injury

Critical care (London, England), 2015-01, Vol.19 (S1), p.P335-P335, Article P335

2015

Volltextzugriff (PDF)

Liquid biopsy“: Analyse molekularer Marker aus Blutproben zur Therapiesteuerung beim Lungenkarzinom

Pneumologie (Stuttgart, Germany), 2017-03, Vol.71 (3), p.151-163

2017

Volltextzugriff (PDF)

Liquid biopsy“: Analyse molekularer Marker aus Blutproben zur Therapiesteuerung beim Lungenkarzinom

TumorDiagnostik & Therapie, 2018-08, Vol.39 (6), p.385-397

2018

Volltextzugriff (PDF)

A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer

Neoplasma, 2010, Vol.57 (1), p.47-54

2010

Volltextzugriff (PDF)

Östrogenrezeptoren und ihre Bedeutung für die Prognose und Therapie des Lungenkarzinoms – neue Erkenntnisse zu einem bisher unterschätzten Mechanismus

Pneumologie (Stuttgart, Germany), 2015-06, Vol.69 (6), p.350-360

2015

Volltextzugriff (PDF)

Relevance of glycosylation-associated genes for tumor progression and metastasis localization in breast cancer

Annals of oncology, 2015-05, Vol.26, p.iii15-iii15

2015

Volltextzugriff (PDF)

227PEvaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

168PValidation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

HLA-J as a new predictive marker in breast cancer for neoadjuvant chemotherapy

Geburtshilfe und Frauenheilkunde, 2020, Vol.80 (10)

2020

Volltextzugriff (PDF)

Molecular classification of bladder cancer. Possible similarities to breast cancer

Der Pathologe, 2016-02, Vol.37 (1), p.52-60

2016

Volltextzugriff (PDF)

Abstract P4-02-12: Comparison of RT-qPCR with consensus immunohistochemistry by three pathologists for ER, PR, HER2 and Ki-67 in Chinese breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-02-12

2019

Volltextzugriff (PDF)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

Cancer management and research, 2021-01, Vol.13, p.6567-6578

2021

Volltextzugriff (PDF)

1 – 25 von 1.102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(942)
Mit Volltextzugriff
(844)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(582)
Life Sciences & Biomedicine
(456)
Humans
(373)
Biological And Medical Sciences
(215)
Female
(189)
Male
(178)
Animals
(170)
Medical Sciences
(147)
Middle Aged
(137)
Adult
(136)
Aged
(93)
Fundamental And Applied Biological Sciences. Psychology
(85)
Physical Sciences
(84)
Technology
(71)
Infectious Diseases
(66)
Neurosciences & Neurology
(65)
Physics
(65)
Mice
(58)
Clinical Neurology
(56)
Treatment Outcome
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)

Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer

Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer

Radiation exposure before and after the introductionof a dedicated total-body CT protocolin multitrauma patients

Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism

Effect of the haemoglobin level on neurologic outcome in patients with severe traumatic brain injury

Liquid biopsy“: Analyse molekularer Marker aus Blutproben zur Therapiesteuerung beim Lungenkarzinom

Liquid biopsy“: Analyse molekularer Marker aus Blutproben zur Therapiesteuerung beim Lungenkarzinom

A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer

Östrogenrezeptoren und ihre Bedeutung für die Prognose und Therapie des Lungenkarzinoms – neue Erkenntnisse zu einem bisher unterschätzten Mechanismus

Relevance of glycosylation-associated genes for tumor progression and metastasis localization in breast cancer

227PEvaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes

168PValidation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)

HLA-J as a new predictive marker in breast cancer for neoadjuvant chemotherapy

Molecular classification of bladder cancer. Possible similarities to breast cancer

Abstract P4-02-12: Comparison of RT-qPCR with consensus immunohistochemistry by three pathologists for ER, PR, HER2 and Ki-67 in Chinese breast cancer patients

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

Suchergebnisse filtern